Abstract
Behavioural symptoms of Alzheimer's disease, such as aggression, may determine the care patients required. Most postmortem neurochemical studies have been of institutionalized patients and conclusions drawn from these may not be valid for all patients. We have shown that serotonin 2 receptors are not lost from 12 of the 13 areas of cerebral cortex examined in the patients assessed to be free of aggressive symptoms. This has been interpreted as representing the relative preservation of cortical interneurones. In contrast choline acetyltransferase activity was reduced in all areas whereas serotonin content was reduced in only 2 of the 4 areas examined.
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer's disease
- ChAT:
-
choline acetyltransferase activity
- GABA:
-
gamma-amino butyric acid
- 5-HT:
-
serotonin
- SLIR:
-
somatostatin-like immuno-reactivity
References
Rosen, W. G., Mohs, R. C., and Davis, K. L. 1984. A new rating scale for Alzheimer's Disease. Am. J. Psychiatry 141:1356–1364.
Hope, R. A., and Fairburn, C. G. 1990. The nature of wandering in dementia: a community based study. Int. J. Geriat. Psychiatry 5:239–245.
Wilkins, R. H., and Brody, I. A. 1969. Alzheimer's Disease. Arch. Neurol. 21:109–110.
Sanford, J. 1975. Tolerance of disability in elderly dependents by supporters at home: its significance for hospital practice. Br. Med. J. iii:471–473.
Chenoweth, B., and Spencer, B. 1986. Dementia: the experience of family caregivers. Gerontologist 26:267–272.
Procter, A. W., and Bowen, D. M. 1988. Aging, the cerebral neocortex and psychiatric disorder. In: Pages 3–20, Finch C. E., Davies, P. (eds) Banbury Report 27: Molecular Neuropathology of Aging. Cold Spring Harbor Laboratory, Cold Spring Harbor.
Palmer, A. M., Stratmann, G. C., Procter A. W., and Bowen, D. M. 1988. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann. Neurol. 23:616–620.
Bowen, D. M., Najlerahim, A., Procter, A. W., Francis, P. T., and Murphy, E. 1989. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc. Natl. Acad. Sci. U.S.A. 86:9504–9508.
Palmer, A. M., Francis, P. T., Benton, J. S., Sims, N. R., Mann, D. M., Neary, D., Snowden, J. S., and Bowen, D. M. 1987. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J. Neurochem. 48:8–15.
Procter, A. W., Lowe, S. L., Palmer, A. M., Francis, P. T., Esiri, M. M., Stratmann, G. C., Najlerahim, A., Patel, A. J., Hunt, A., and Bowen, D. M. 1988. Topographical distribution of neurochemical changes in Alzheimer's disease. J. Neurol. Sci. 84:125–140.
McKhann, G., Drachman, D., Folstein, M. F., Katzman, R., Price, D., and Stadlan, E. M. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939–944.
Lowe, S. L., Francis, P. T., Procter, A. W., Palmer, A. M., Davison, A. N., and Bowen, D. M. 1988. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. Brain 3:785–799.
Burns, A., Jacoby, R., and Levy, R. 1990. Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behavior. Br. J. Psychiatry 157:86–94.
Burns, A., Jacoby, R., and Levy, R. 1990. Psychiatric phenomena in Alzheimer's disease III: Disorders of mood. Br. J. Psychiatry 157:81–86.
Teri, L., Larson, E. B., and Reifler, B. V. 1988. Behavioral disturbance in dementia of the Alzheimer's type. J. Am. Geriatr. Soc. 36:1–6.
Knesevitch, J. W., Martin, R. L., Berg, L., and Danziger, W. 1983. Preliminary report on affective symptoms in the early stages of senile dementia of the Alzheimer type. Am. J. Psychiatry 140:233–235.
Merriam, A. E., Aronson, M. K., Gaston, P., Wey, S-L., and Katz, I. 1988. The psychiatric symptoms of Alzheimer's disease. J. Am. Geriatr. Soc. 36:7–12.
Reifler, B. V., Larson, E., and Hanley, R. 1982. Coexistence of cognitive impairment and depression in geriatric outpatients. Am. J. Psychiatry 139:623–626.
Birkett, D. P. 1972. The psychiatric differentiation of senility and arteriosclerosis. Br. J. Psychiatry 120:321–325.
Reisberg, B., Borenstein, J., Salob, S. P., Ferris, S. H., Fransen, E., and Georgotas, A. 1987. Behavioral symptoms in Alzheimer's Disease: Phenomenology and treatment. J. Clin. Psychiatry 48 [5, Suppl]:9–15.
Swearer, J. M., Drachman, D. A., O'Donnell, B. F., and Mitchell, A. L. 1988. Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity. J. Am. Geriatr. Soc. 36:784–790.
Ryden, M. B. 1988. Aggressive behavior in persons with dementia who live in the community. Alzheimer. Dis. Assoc. Disord. 2:342–355.
Procter, A. W., Palmer, A. M., Francis, P. T., Lowe, S. L., Neary, D., Murphy, E., Doshi, R., and Bowen, D. M. 1988. Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J. Neurochem. 50:790–802.
Cross, A. J, Crow, T. J., Johnson, J. A, Bloom, S. R., and Corsellis, J. A. N. 1984. Serotonin receptor changes in dementia of Alzheimer type. J. Neurochem. 43:1574–1581.
Perry, E. K., Perry, R. H., Candy, J. M., Fairbairn, A. F., Blessed, G., Dick, D. J., and Tomlinson, B. E. 1984. Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease. Neurosci. Lett. 51:353–357.
Reynolds, G. P., Arnold, L., Rossor, M. N., Iversen, L. L., Mountjoy, C. Q., and Roth, M. 1984. Reduced binding of [3H] ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type. Neurosci. Lett. 44:47–51.
Dewar, D., Graham, D. I., and McCulloch, J. 1990. 5 HT2 receptors in dementia of Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus. J. Neural Transm. Park. Dis. Dement. Sect. 2:129–137.
Swigar, M. E., Benes, F. M., Rothman, S. L. G., Opsahl, C., and Dowds, M. M. 1985. Behavioral correlates of computed tomographic (CT) scan changes in older psychiatric patients. J. Am. Geriatr. Soc. 33:96–1034.
Tork, I., and Hornung, J-P. 1990. Raphe nuclei and the serotonergic system.in Pages 1001–1022, Paxinos, G. (ed.) The human nervous system. Academic Press, Sandiago.
Francis, P. T., Pangalos, M. N., Pearson, R. C. A., Middlemiss, D. N., Stratmann, G. C., and Bowen, D. M. 1991. 5-HT1A but not 5-HT2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin. J. Pharmacol. Exp. Therapeut. (in press).
Bowen, D. M., Francis, P. T., Procter, A. W., and Young, A. B. 1991. Treatment of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. (in press).
Nyth, A. L., and Gottfries, C. G. 1990. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. Brit. J. Psychiat. 157:894–901.
Hermann, C., Stern, R. G., Losonzey, M. F., and Jaff, S. 1991. Diagnostic and Pharmacological Approaches in Alzheimer's disease. Drugs & Aging 2:144–162.
Dresse, A., and Scuvee-Moreau, J. 1988. Electrophysiological effects of tianeptine on rat locus coeruleus, raphe dorsalis, and hippocampus activity. Clin. Neuropharmacol. 11:551–558.
Lawlor, B. A., Sunderland, T., Mellow, A. M., Hill, J. L., Molchan, S. E., and Murphy, D. L. 1989. Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease: A controlled study. Arch. Gen. Psychiat. 46:542–549.
Author information
Authors and Affiliations
Additional information
Special issue dedicated to Dr. Alan N. Davison.
Rights and permissions
About this article
Cite this article
Procter, A.W., Francis, P.T., Stratmann, G.C. et al. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Neurochem Res 17, 917–922 (1992). https://doi.org/10.1007/BF00993268
Issue Date:
DOI: https://doi.org/10.1007/BF00993268